San Diego-based BioAtla is cutting approximately 70% of its workforce as it explores strategic options including asset sales, licensing transactions, and strategic partnerships for its pipeline of antibody therapeutics targeting solid tumors.
All entries for: BioAtla
May 6, 2025
BioAtla
Neutral Outlook
San Diego, CA
51-200 employees
Thus, while it is unclear how certain provisions of the IRA will be implemented, the IRA will likely have a significant impact on the pharmaceutical industry. It is unclear to what extent other statutory, regulatory, and administrative initiatives will be enacted and implemented, and to what extent these or any future legislation or regulations by the current administration or subsequent administrations will have on our business, including market acceptance, and sales, of our products and product candidates.
Disease Area: Oncology
Drug Type: Biologic